An employee checks the production of chloroquine phosphate at a pharmaceutical company in Nantong city in east China's Jiangsu province, Thursday, Feb. 27, 2020. (Getty Images)

'I have a feel­ing': Trump-en­dorsed malar­ia drug fails to pass muster in small Chi­nese coro­n­avirus study

De­spite the FDA’s re­luc­tance to en­dorse with­out de­fin­i­tive clin­i­cal tri­al da­ta the decades-old an­ti-malar­i­al drugs chloro­quine and de­riv­a­tive hy­drox­y­chloro­quine as treat­ments to com­bat the coro­n­avirus scourge, in re­cent days Pres­i­dent Trump has trum­pet­ed his faith — on the ba­sis of a ‘feel­ing’ — that the drugs would work. Now, a key an­a­lyst has found tri­al da­ta that con­tra­dict the pos­i­tive con­clu­sions of a small Chi­nese study that re­searchers ini­tial­ly based on their en­thu­si­asm on.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.